Staging Acute Pancreatitis: Where Are We Now?

Pancreatology

Volumn 1, Issue 3, 2001, Pages 201-206

  Dervenis, Christos G ^a  

^a AGIA OLGA HOSPITAL   (Greece)

Author keywords

Acute pancreatitis; Biochemical markers; Imaging; Scoring systems; Staging

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER;

ACUTE DISEASE; HUMAN; PANCREATITIS; PATHOLOGY; PREDICTION AND FORECASTING; REVIEW;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; HUMANS; PANCREATITIS; PREDICTIVE VALUE OF TESTS;

EID: 0035553344     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055810     Document Type: Review

References (55)

1. Bradley EL: A clinically based classification system for acute pancreatitis: Summary of the international symposium on acute pancreatitis. Arch Surg 1993;128:586-590.
2. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I: Diagnosis, objective assessment of severity and management of acute pancreatitis. The Santorini Consensus Conference. Int J Panceatol 1999;25: 195-210.
3. Ranson J, Rifkind K, Turner J: Prognostic signs and non-operative peritoneal lavage in acute pancreatitis. Surg Obstet Gynecol 1976; 143:209-219.
4. McKay C, Imrie C: Staging of acute pancreatitis: is it important? Surg Clin North Am 1999; 79:733-743.
5. Corfield A, Williamson R, McMahon M, et al: Prediction of severity in acute pancreatitis: Prospective comparison of three prognostic indices. Lancet 1985;ii:403-407.
6. Wilson C, Heath D, Imrie C: Prediction of outcome in acute pancreatitis: A compcrative study of APACHE II, clinical assessment and multiple factor scoring system. Br J Surg 1990; 77:1260-1264.
7. Larvin M, McMahon M: APACHE II score for assessment and monitoring of acute pancreatitis. Lancet 1989;ii:201-205.
8. Dickson AP, Imrie CW: The incidence and prognosis of body wall ecchymosis in acute pancreatitis. Surg Gynaecol Obstet 1984;159: 343-347.
9. Toh SKC, Walters J, Johnson CD: APACHE-O a new predictor of severity in acute pancreatitis. Gut 1996;38(suppl 1):A35.
10. Lankisch PG, Schirren CA: Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas 1990;5:626-629.
11. Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN: Obesity: An important prognostic factor in acute pancreatitis. Br J Surg 1993;80:484-486.
12. Talamini G, Bassi C, Falconi M, et al: Risk of death from acute pancreatitis. Int J Pancreatol 1996;19:15-24.
13. Porter KA, Banks PA: Obesity as a predictor of severity in acute pancreatitis. Int J Pancreatol 1991;10:247-252.
14. Moulton JS: The radiologic assessment of acute pancreatitis and its complications. Pancreas 1991;6(suppl 1):13-22.
15. Talamini G, Uomo G, Pezzilli R, et al: Renal function and chest X-rays in the assessment of 539 acute pancreatitis patients. Gut 1997;41: A136.
16. Brown A, Orav J, Banks PA: Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas 2000;20: 367-372.
17. Balthazar E, Ranson J, Naidich D, et al: Acute pancreatitis: Prognostic value of CT. Radiology 1985;156:767-772.
18. London N, Leese T, Lavelle J: Rapid bolus contrast-enhanced computed tomography in acute pancreatitis: A prospective study. Br J Surg 1991;78:1452-1456.
19. Salfuddin A, Ward J, Ridway J, Chalmers A: Comparison of MR and CT scanning in severe acute pancreatitis: Initial experience. Clin Radiol 1993;48:111-116.
20. Lecense R, Taourle P, Bret P, Atri M, Reinhold C: Acute pancreatitis: Interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome. Radiology 1999; 211:727-735.
21. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC: Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynaecol Obstet 1974;139:69-81.
22. Ranson JHC: The timing of biliary surgery in acute pancreatitis. Ann Surg 1979;189:654-662.
23. Imrie CW, Benjamin IS, McKay AJ, McKenzie I, O'Neill J, Blumgart LH: A single centre double blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337-341.
24. Osbourne DH, Imrie CW, Carter DC: Biliary surgery in the same admission for gallstone-associated acute pancreatitis. Br J Surg 1981; 68:758-761.
25. Wilson C, Heath D, Imrie C: Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77:1260-1264.
26. Knaus W, Wagner DP, Draper E, Zimmerman J: APACHE II final form and national validation results of a severity of disease classification system. Crit Care Med 1984;12:213.
27. Johnson C, Toh S: Prediction of severity in acute pancreatitis; in Johnson C, Imrie C (eds): Pancreatic Disease: Towards the Year 2000. Berlin, Springer, 1998, pp 31-39.
28. 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with C reactive protein. Dig Dis Sci 1995;40:2341-2348.
29. Leser HG, Gross H, Scheibenbogen C, et al: Elevation of interleukin 6 concentration precedes acute phase response, and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-785.
30. Uhl U, Büchler M, Malfertheiner P, Martini M, Beger HG: PMN elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991;6:253-259.
31. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J: Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe pancreatitis. Gut 1992;33:1126-1128.
32. Messmann H, Grune S: TNF and TNF receptors P55 and P75 in mild and severe acute pancreatitis. Gastroenterology 1997;112:A464.
33. Paajainen H, Laato M, Jaakkola M, Pulkki A, Niinikoski J, Nordback I: Serum tumour necrosis factor compared with C-reactive protein in the assessment of severity of acute pancreatitis. Br J Surg 1995;82:271-273.
34. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KHC: Serum concentration of inflammatory mediators related to organ failure with acute pancreatitis. Br J Surg 1996;83:349-353.
35. Gross V, Schölmerich J, Leser HG, et al: Granulocyte elastase in assessment of severity of acute pancretitis: Comparison with acute-phase protein C reactive protein, α1-antitrypsin and protease inhibitor α2-macroglobulin. Dig Dis Sci 1990;35:97-105.
36. Chen CC, Wang SS, Lee FY, Chang FY, Lee SD: Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-218.
37. Schölmerich J, Heinisch A, Leser H: Diagnosis approach to acute pancreatitis: Diagnosis, assessment of etiology and prognosis. HepatoGastroenterol 1993;40:531-537.
38. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F: Role of interleukin 6 in acute pancreatitis. Gut 1992;33:1264-1267.
39. Heath DI, Cruikshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW: Role of interleukin 6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34: 41-45.
40. Pezzilli R, Billi P, Miniero R, Barakat B: Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997;42:1469-1472.
41. Chen CC, Wang SS, Lu RH, Chang FY, Lee SD: Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis. Gut 1999;45: 895-899.
42. Rau B, Steinbach G, Mayer J, Gansauge F, Grünert A, Beger HG: The role of interleukin-8 in the severity assessment of septic complications in necrotising pancreatitis. Digestion 1997;58(suppl 2):11.
43. Uhl U, Büchler M, Malfertheiner P, Martini M, Beger HG: PMN elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991;6:253-259.
44. Dominguez-Muñoz JE, Carballo F, Garcia MJ: Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: Results of a multicenter study. Br J Surg 1991;78:1230-1234.
45. Gudgeon M, Heath DI, Hurley P, et al: Trypsinogen activation peptide assay in the early severity prediction of acute pancreatitis. Lancet 1990;335:4-8.
46. Tenner S, Fernandez del Castillo C, Warshaw A, et al: Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997;21:105-110.
47. Heath D, Wilson C, Gudgeon M, et al: Trypsinogen activation peptide concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1999;35:1311-1315.
48. Neoptolemos, Kemppainen E, Mayer J, et al: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study. Lancet 2000;335:1955-1960.
49. Appelros S, Thim A, Borgstrom A: Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998;42:97-102.
50. Büchler M, Malfertheiner P, Schadlich H, et al: Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 1989;97:1521-1526.
51. Nevalainen JJ: The role of phospholipase A in acute pancreatitis. Scand J Gastroenterol 1980; 15:641-650.
52. 2 activity in acute pancreatitis: An early guide to severity. Br J Surg 1989;76: 731-732.
53. Iovanna JL, Keim V, Nordback I, et al: Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Multicentric Study Group on Acute Pancreatitis. Gastroenterology 1994;106:728-734.
54. Pezzilli R, Billi P, Migliori M, Gullo L: Clinical value of pancreatitis-associated protein in acute pancreatitis. Am J Gastroenterol 1997; 92:1887-1890.
55. Johnson C, Phillips S, Toh S, Campell M: An individual probability index for prediction of complications in acute pancreatitis. Gut 1998; 42(suppl 1):A10.